Absci (ABSI) Change in Receivables (2024 - 2025)
Absci (ABSI) reported Change in Receivables of -$1.0 million for Q4 2025, up 33.33% on a YoY basis from -$750000.0 in Q4 2024, and down 433.33% sequentially from $300000.0 in Q3 2025.
Absci (ABSI) Change in Receivables (2024 - 2025) Analysis & Trends
Absci (ABSI) has 2 years of Change in Receivables data on file, last reported at -$1.0 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables rose 33.33% year-over-year to -$1.0 million; the trailing twelve-month figure through Mar 2026 stood at -$1.4 million (down 207.12% YoY), and the FY2024 full-year result was -$2.2 million, down 436.19% from the prior year.
- Change in Receivables eased to -$1.0 million in Q4 2025, from $300000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.4 million in Q3 2024 to a low of -$2.1 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.00 Mn |
| Dec 31, 2025 | -1.00 Mn |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | -684,000.00 |
| Jun 30, 2025 | -684,000.00 |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | -2.15 Mn |
| Mar 31, 2024 | -2.15 Mn |